PCA-ESCITALOPRAM escitalopram (as oxalate) 10 mg tablet blister

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

escitalopram oxalate, Quantity: 12.74 mg

Disponible depuis:

Ipca Pharma (Australia) Pty Ltd

DCI (Dénomination commune internationale):

escitalopram oxalate

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: purified talc; macrogol 400; titanium dioxide; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; hypromellose; croscarmellose sodium

Mode d'administration:

Oral

Unités en paquet:

56, 14, 98, 28

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Treatment of major depression.,Treatment of social anxiety disorder (social phobia).,Treatment of generalised anxiety disorder.,Treatment of obsessive-compulsive disorder.

Descriptif du produit:

Visual Identification: White to off-white, oval, biconvex, film-coated tablet with 'C4' embossed on one side and a notch break-line on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 48 Months; Container Temperature: Store below 30 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2012-09-25